BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 416166)

  • 1. Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts.
    Hurme M; Chandler PR; Hetherington CM; Simpson E
    J Exp Med; 1978 Mar; 147(3):768-75. PubMed ID: 416166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-cell responses to H-Y: mapping of the Ir genes.
    Hurme M; Hetherington CM; Chandler PR; Simpson E
    J Exp Med; 1978 Mar; 147(3):758-67. PubMed ID: 416165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of transplant rejection.
    Butcher GW; Howard JC
    Transplantation; 1982 Oct; 34(4):161-6. PubMed ID: 6815843
    [No Abstract]   [Full Text] [Related]  

  • 4. Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.
    Klein J; Geib R; Chiang C; Hauptfeld V
    J Exp Med; 1976 Jun; 143(6):1439-52. PubMed ID: 775014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in histocompatibility immunogenetics.
    Snell GD
    Adv Genet; 1979; 20():291-355. PubMed ID: 117684
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
    Rosenberg AS; Mizuochi T; Singer A
    J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
    Wettstein PJ; Colombo MP; Jaenisch R
    J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-Y status of X/X Sxr' male mice: in vivo tests.
    Simpson E; Chandler P; Hunt R; Hogg H; Tomonari K; McLaren A
    Immunology; 1986 Mar; 57(3):345-9. PubMed ID: 3514439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and agglutinating H-Y antibodies in multiparous female mice.
    Krupen-Brown K; Wachtel SS
    Transplantation; 1979 Jun; 27(6):406-9. PubMed ID: 111380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong histocompatibility and cell-mediated cytotoxic effects of a single Mls difference demonstrated using a new congenic mouse strain.
    Berumen L; Halle-Pannenko O; Festenstein H
    Eur J Immunol; 1983 Apr; 13(4):292-300. PubMed ID: 6221931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
    Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
    Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of graft size on the induction of immunity versus tolerance to H-Y in H-2k strains of mice.
    Ashman RB
    Immunogenetics; 1985; 22(6):585-91. PubMed ID: 3908302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen.
    Gordon RD; Mathieson BJ; Samelson LE; Boyse EA; Simpson E
    J Exp Med; 1976 Sep; 144(3):810-20. PubMed ID: 784891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
    Billings P; Burakoff SJ; Dorf ME; Benacerraf B
    J Exp Med; 1978 Aug; 148(2):341-50. PubMed ID: 100567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-type hypersensitivity responses to H-Y: characterization and mapping of Ir genes.
    Liew FY; Simpson E
    Immunogenetics; 1980; 11(3):255-66. PubMed ID: 6793506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.